North America Pharmaceutical Blister Packaging Market Research Report: Forecast (2024-2030)

Market Insights & Projections: North America Pharmaceutical Blister Packaging Market (2024-30):

The North America Pharmaceutical Blister Packaging Market size was valued at USD 3.2 billion in 2023 & is estimated to grow at a CAGR of around 6.4% during the forecast period, i.e., 2024-30. With the rising demand for pharmaceutical blister packaging across a range of end-users, such as the pharmaceutical sector, the market is envisioned to register a modest growth percentage in the years ahead. When it comes to packaging products that need to be protected from external factors, blister packs are growing in popularity.

Besides being applicable to other medical devices, they can be utilized for injectable vials, inhalers, capsules, and tablets. They are also well-liked for preserving consumables like medicines, etc. As this packaging offers great safety solutions to protect any kind of pharmaceutical product or medication, its demand is foreseen to heighten. The US Food and Drug Administration (FDA) in the United States & Health Canada in Canada are two organizations overseeing North America's pharmaceutical sector.

To assure product safety, efficiency, and quality, these organizations have established several guidelines & standards for pharmaceutical packaging, including blister packing. The stringent regulations & the rising need for this packaging from the manufacturers & consumers, as well as the progression in over-the-counter drugs, are also proliferating the usage of pharmaceutical blister packaging in the North America Pharmaceutical Blister Packaging Market.

The region has a well-established pharmaceutical industry & is home to the leading & innovative pharma & biopharma industries and drug developers, owing to its high investments & rigorous R&D. Since, the past few decades the industry has shown tremendous growth, owing to which much larger pool of consumers have access to all types of medication & to maintain the same easy availability of the medicines numerous pharmaceutical manufacturers are working at a great pace & produces a huge amount of medications.

Moreover, owing to the outbreak of COVID-19, several medical industries enhanced their R&D as well as extended their manufacturing sector to satisfy the soaring need for drugs & vaccines across the region. Thus, in line with the upgrading production of medication the pharmaceutical blister packaging has been registering extraordinary demand, which is eventually leading to enhanced market growth.

Additionally, the concern about the manufacturing of prescription drugs at the retail level by pharmaceutical technologists or chemists regarding sensitive medications that could have a harmful impact when being transported from container to container in the open environment of the supermarket & drug store is one of the aspects that is encouraging the adoption of pharmaceutical blister packaging. As this packaging protects the products against humidity, contamination for a prolonged period of time, and destruction, thereby increasing their shelf life. Along with this, the rise in the adoption for developing sustainable blister packaging among the regional manufactures is revolutionizing the North America Pharmaceutical Blister Packaging Market & would be a potential trend in the industry.

On top of that, pharmaceutical firms that serve the drug sector are spending capital to expand their manufacturing facilities in North America. For instance, Lubrizol Life Science Health unveiled Apisolex, a brand-new solubility-improving excipient for parenteral medicinal formulations, in March 2022. Hence, the upscaling expenditure in the production of drugs by the leading pharmaceutical players is presumed to increase the requirement for blister packaging in the following years.

North America Pharmaceutical Blister Packaging Market Driver:

Rising Spending Capitals by Pharmaceutical Sector to Expand Drugs Manufacturing to Influence the Market Growth – With the surging percentage of individuals suffering from several types of diseases, North America is witnessing high demand for medication & drugs. Also, in consideration of the recent market situation the pharma sector is investing heavily in R&D activities to enrich & modernize the current production lines. The sector is spending capital on the development of new products & to suffice the need for existing drugs. Numerous leading players have several pharmaceutical drugs in their R&D pipeline. For instance:

• In 2023, Eli Lilly and Co announced that it would make an additional investment in its new manufacturing sites in the US to support the production of its recently approved cancer drug.

Hence, owing to the rising R&D activities & investment by the companies to launch or produce new drugs or medication is creating a massive opportunity for the North America Pharmaceutical Blister Packaging Market. Further, the region is following an advanced & newer manufacturing process, which is more flexible & could expedite the production process, thus strengthening domestic drug manufacturing to sustain the medical requirement of the patients. Therefore, with the soaring production of drugs & medication, owing to the upscaling population suffering from diseases, there would be a boost in demand for packaging. This, in turn, would aid in creating a positive market outlook in the upcoming years.

North America Pharmaceutical Blister Packaging Market Challenge:

Compliance with Strict Regulation to Hinder the Market – North America has no such comprehensive legislation regulating the pharmaceutical sector. However, via FDI, the US does have the authority to regulate the pharmaceutical industry & related sectors to ensure that the industry is meeting safety standards. Therefore, the companies are enforced to follow the regulations to meet the satisfactory need. The strict regulations imposed on blister packaging are creating a barrier to the expansion of the market.

In adherence to the regulations, there should be no small defect, as it would abolish the entire product, which would adversely affect the manufacturer’s profit margin. Moreover, as per the FDI, the packaging must have the name of the manufacturer, lot number, expiration date, bar code, etc. Hence, to fulfill all the regulation extra vigilance & effort is required, leading to surplus cost, time, and resource, further creating a challenge for the manufacturers & eventually hindering the growth of the North America Pharmaceutical Blister Packaging Market.

North America Pharmaceutical Blister Packaging Market Trend:

Innovation & Inclination Towards Sustainable Pharmaceutical Packaging –   As we all know, North America is the home to the pharmaceutical sector & the countries of the region, such as the US, and several others, are always focused on improvising & adopt environmentally friendly things. Thus, to overcome environmental issues like carbon emissions, the companies in the region are inclining towards sustainable blister packaging. Several leading companies are investing in blister packaging to satisfy their sustainability targets, improve the reputation of their brands, and win over customers, now that sustainability is a critical factor. For instance:

• In 2021, Amcor revealed customer trials for thermoform blister packaging made of recyclable polyethylene. The new packaging offers a more environmentally friendly substitute for the most popular type of healthcare packaging while still meeting the strict specifications of highly specialized & regulated pharmaceutical packaging.

Consequently, owing to the cutting-edge tactic, blister packaging aims to lessen the environmental impact of conventional packaging materials, simultaneously advancing sustainability efforts. Thus, sustainability packaging has become trending in the North America Pharmaceutical Blister Packaging Market.

North America Pharmaceutical Blister Packaging Market (2024-30): Segmentation Analysis

The North America Pharmaceutical Blister Packaging Market study of MarkNtel Advisors evaluates & highlights the major trends & influencing factors in each segment & includes predictions for the period 2024–2030 at the regional & national levels. Based on the analysis, the market has been further classified as:

Based on Material Type:

• Polyethylene Terephthalate (PET)
• Polyethylene (PE)
• Polyvinyl Chloride (PVC)
• Polyvinylidene chloride (PVDC)

• PVDC 20 GSM
• PVDC 40 GSM
• PVDC 60 GSM
• PVDC 90 GSM
• PVDC 120 GSM

• Aclar Films

• Aclar Films 15 microns
• Aclar Films 23 microns
• Aclar Films 51 microns

• Aluminium
• Others (Polyolefin (PO), Paper Solutions, etc.)

Polyethylene Terephthalate (PET) is estimated to be the most prominent material type in the North America Pharmaceutical Blister Packaging market in the forecast years, owing to its strong durability & transparency. This material can withstand high temperatures & act as a barrier to gas & moisture, thus becoming a preferable option for the North American pharmaceutical packaging sector. Further, owing to its high sustainable aspect, its demand is foreseen to enhance in the North America Pharmaceutical Blister Packaging Market during the forthcoming period.

Based on Technology:

• Thermoforming
• Cold Forming

Thermoforming is presumed to be the most adopted technology by manufacturers in the market. Faster production & low expense for production in comparison to cold forming are the primary aspects that are inclining the blister packaging manufacturers' interest in the technology. Thermoforming offers safe transit due to its smaller & tightly defined compartments, which lessens the possibility of damage, and visibility owing to transparent blister plastic & privilege of enormous customization. Moreover, with its ability to manufacture high volumes for blister packaging, hygiene, and reliability, it is gaining prevalence among manufacturers, thus becoming one of the contributors in upscaling the revenue growth of the North American market.

North America Pharmaceutical Blister Packaging Market (2024-30): Regional Analysis

Geographically, the North America Pharmaceutical Blister Packaging Market expands across:

• The US
• Canada
• Mexico

The US has captured the dominating share of the market & is anticipated to be the flourishing region in terms of consumption & development of pharmaceutical products. With the strong foothold of the leading players, such as Amcor PLC, and several others, the US is regarded as the significant country aiding in sufficing the medical needs of the domestic as well as the regional population.

The rising elderly population is increasing the rate of diseases in the country, further developing a large scope for pharmaceutical products, which is driving the Pharmaceutical Blister Packaging Market in the country. For instance, the production of pharmaceutical products is anticipated to reach around 365 thousand, by the end of 2024, as per the US Census Bureau. Consequently, due to the growing chronic diseases in the US, there is & would be a surge in the production of newly launched or effective drugs & medications, which is expected to contribute to the growth of the North America Pharmaceutical Blister Packaging Market during 2024-30.

North America Pharmaceutical Blister Packaging Industry Recent Development:

• 2022: AmSky, one of the leading recycle-ready healthcare blister system innovations by Amcor, bested the US Plastics Pact Sustainable Packaging Innovation Award in the Recyclability category. It offers more sustainable packaging & optimizes carbon emission.

Gain a Competitive Edge with Our North America Pharmaceutical Blister Packaging Market Report

• North America Pharmaceutical Blister Packaging Market Report by Markntel Advisors provides a detailed & thorough analysis of market size, growth rate, competitive landscape, and key players. This comprehensive analysis helps businesses gain a holistic understanding of the market dynamics & make informed decisions.
• This report also highlights current market trends & future projections, allowing businesses to identify emerging opportunities & potential challenges. By understanding market forecasts, companies can align their strategies & stay ahead of the competition.
• North America Pharmaceutical Blister Packaging Market Report aids in assessing & mitigating risks associated with entering or operating in the market. By understanding market dynamics, regulatory frameworks, and potential challenges, businesses can develop strategies to minimize risks & optimize their operations.